摘要
体成分指标包含身高、体重、脂肪含量和骨骼肌含量等多方面的内容,这些指标在肿瘤患者的治疗过程中实时变化,不仅与治疗的效果密切相关,也在预后评估中发挥着重要的作用。本文详细介绍了淋巴瘤患者治疗过程中体成分指标的变化及其在评估疗效与预后中的作用,并着重关注了体成分指标在接受造血干细胞移植的淋巴瘤患者中的作用。
Body composition indicators include height,weight,fat content and skeletal muscle content and etc.These indicators,which change during different stages of treatment in cancer patient,are not only closely related to the treatment efficacy but also play an important role in prognosis evaluation.This article details the changes of various body composition indicators during the treatment in lymphoma patients,as well as their indicating effects on prognosis,and focuses on the role of these indicators in lymphoma patients receiving hematopoietic stem cell transplantation.
作者
黄姗姗
牛杨
吴江
Huang Shanshan;Niu Yang;Wu Jiang(Department of Clinical Nutrition,Xinhua Hospital Affiliated toShanghai Jiaotong University,School of Medcine,Shanghai 200092,China)
出处
《临床荟萃》
CAS
2019年第6期496-501,共6页
Clinical Focus
关键词
淋巴瘤
体成分指标
治疗
预后
lymphoma
body composition index
treatment
prognosis
